Enhanced In Vitro Magnetic Cell Targeting of Doxorubicin-Loaded Magnetic Liposomes for Localized Cancer Therapy

Area of Science:

• Nanomedicine
• Biotechnology
• Oncology

Background:

• Chemotherapy effectiveness is limited by poor drug targeting and low nanoparticle uptake in cancer cells.
• Localized treatment strategies are needed to improve therapeutic efficacy and reduce systemic side effects.

Purpose of the Study:

• To fabricate and characterize doxorubicin-loaded magnetic liposomes for targeted liver cancer therapy.
• To evaluate the magnetic targeting efficiency and in vitro anticancer activity of the developed nanocarriers.

Main Methods:

• Fabrication and characterization of doxorubicin-loaded magnetic liposomes.
• In vitro assessment of colloidal stability, superparamagnetic behavior, and drug loading.
• Evaluation of enhanced cell uptake under magnetic field and medium flow.
• Cytotoxicity studies on HepG2 liver cancer cells.
• Numerical modeling to validate magnetic targeting predictions.

Main Results:

• Magnetic liposomes exhibited colloidal stability, superparamagnetic properties, and efficient drug loading.
• External magnetic field significantly enhanced nanocarrier uptake in a localized area under flow conditions.
• Drug-loaded magnetic liposomes demonstrated significant cytotoxicity against HepG2 cells (50% viability reduction at 24h, 80% at 72h).
• Plain nanocarriers showed no anti-proliferative effects, confirming formulation safety.
• Numerical model accurately predicted liposome accumulation under varying conditions.

Conclusions:

• Doxorubicin-loaded magnetic liposomes show high targeting efficiency and potent anticancer activity for liver malignancies.
• Magnetic targeting enhances drug delivery and therapeutic outcomes, offering a promising localized chemotherapy approach.
• The formulation's superparamagnetic nanoparticles suggest potential theranostic applications.
• This magnetic drug targeting strategy is a valuable tool for pre-clinical cancer research.